Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • What is the future of people suffering from Autism after COVID-19?

NIPGR Life Science / Plant Science & Botany Research Fellow Job

Molecules for Life- Glutaredoxin System

What is the future of people suffering from Autism after COVID-19?
  • BiotechToday
  • World

What is the future of people suffering from Autism after COVID-19?

bioxone October 14, 2020October 14, 2020

Devyani Goswami, Amity University Kolkata

The pandemic has affected the psychological health of every person in this world. The constant fear of uncertainty has lead to an increase in anxiety and depression. The most vulnerable to this pandemic are the people suffering from Autism Spectrum disorder (ASD). Autism Spectrum disorder affects the nervous system impairs the ability to communicate and interact, affects the cognitive, emotional, social, and physical health of the affected individual.


A study was conducted, where parents of children suffering from ASD and normal healthy children were asked to fill a questioner consisting of 40 questions. The main objective was to determine the impact of COVID-19 on the wellbeing, socio-demographic, and clinical characteristics of the children.
The researchers concluded,” The COVID-19 emergency resulted in a challenging period for 93.9% of families, increased difficulties in managing daily activities, especially free time (78.1%) and structured activities (75.7%), and, respectively, 35.5% and 41.5% of children presenting with more intense more frequent behaviour problems.”
Even though ASD patients receive proper treatment, but it would be better to prepare for the future.

Also read: Basics of immunological tolerance -Why are autoimmune diseases on a rise?

REFERENCE:

Psychological and behavioural impact of COVID-19 in Autism Spectrum Disorder: An Online Parent Survey – Marco Colizzi, Elena Sirioni, […], and Leonardo Zoccante
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349059/

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Autism Spectrum disorder (ASD) COVID-19

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • DNA-Tales
  • Scientists' Corner

Molecules for Life- Glutaredoxin System

bioxone October 14, 2020

Esha Sircar & Dr. Rajib Sengupta, Amity Institute of Biotechnology, Amity University Kolkata Prof. Peter Reichard and Prof. Arne Holmgren are considered as two redox pioneers from Karolinska Institute (Sweden) for their enormous contribution to the research focused on thiol-dependent cellular redox homeostasis, related to cancer and many other diseases/disorders. In 1964, Prof. Peter Reichard […]

Glutaredoxin

Related Post

  • BiotechToday
  • World

Closteroviridae: An exceptional virus family in wild citrus plants

BioTech Today July 15, 2021July 15, 2021

Sayak Banerjee, Amity University Kolkata Viromics or viral metagenomics techniques have led to the characterization of many new plant viruses. This has been broadening our understanding of the evolution and ecology of plant viruses in nature. Generally, the knowledge regarding citrus viruses has been highly inclined towards virus pathology in cultivated orchards. Recently, scientists have […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Genetic biobank: a repository for the prevention of SIDS

BioTech Today July 8, 2021July 7, 2021

Arya Sukumar, College of Agriculture, Vellayani Groundbreaking research by the team of Professor Leanne Dibbens has formulated a genetic biobank that helps to identify the mechanisms involved in Sudden Infant Death Syndrome (SIDS) in newborn babies so that future work can stop SIDS from occurring. What is Sudden Infant Death Syndrome (SIDS)?                                                                       Sudden […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Gene therapy clinical trials for rare Angelman syndrome put on hold

bioxone November 7, 2020November 6, 2020

Surupa Chakraborty, Amity University Kolkata A new gene therapy clinical trial for treating Angelman syndrome has been put to hold after two candidates temporarily lost their ability to walk. GTX102, the drug used in the clinical trial was developed by a California-based biopharmaceutical company Ultragenyx, in collaboration with GeneTx, a Florida-based biotech startup. The trial […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy